Heuck-Knubel K, Proszkowiec-Weglarz M, Narayana J, Ellestad LE, Prakobsaeng N, Porter TE. Identification of cis elements necessary for glucocorticoid induction of growth hormone gene expression in chicken embryonic pituitary cells. Am J Physiol Regul Integr Comp Physiol 302: R606 -R619, 2012. First published December 7, 2011; doi:10.1152/ajpregu.00492.2011 treatment of rat or chicken embryonic pituitary (CEP) cells induces premature production of growth hormone (GH). GC induction of the GH gene requires ongoing protein synthesis, and the GH genes lack a canonical GC response element (GRE). To characterize cis-acting elements and identify trans-acting proteins involved in this process, we characterized the regulation of a luciferase reporter containing a fragment of the chicken GH gene (Ϫ1727/ϩ48) in embryonic day 11 CEP cells. Corticosterone (Cort) increased luciferase activity and mRNA expression, and mRNA induction was blocked by protein synthesis inhibition. Through deletion analysis, we identified a GCresponsive region (GCRR) at Ϫ1045 to Ϫ954. The GCRR includes an ETS-1 binding site and a degenerate GRE (dGRE) half site. Nuclear proteins, including ETS-1, bound to a GCRR probe in electrophoretic mobility shift assays, and Cort regulated protein binding. Using chromatin immunoprecipitation, we found that ETS-1 and GC receptor (GR) were associated with the GCRR in CEP cells, and Cort increased GR recruitment to the GCRR. Mutation of the ETS-1 site or dGRE site in the Ϫ1045/ϩ48 GH reporter abolished Cort responsiveness. We conclude that GC regulation of the GH gene during development requires cis-acting elements in the GCRR and involves ETS-1 and GR binding to these elements. Similar ETS-1 elements/dGREs are located in the 5=-flanking regions of GH genes in mammals, including rodents and humans. This is the first study to demonstrate involvement of ETS-1 in GC regulation of the GH gene during embryonic development in any species, enhancing our understanding of GH regulation in vertebrates.
ONSET OF GROWTH HORMONE (GH) secretion and differentiation of GH-producing cells (somatotrophs) in the anterior pituitary during embryonic development are processes still not wholly understood. Differentiation of somatotrophs naturally occurs between embryonic day (e) 14 and e16 in the chicken (41) and between e17 and e18 in the rat (36) . Plasma corticosterone (Cort) and ACTH dramatically increase between e11 and e17 in the chicken (25) , mimicking the pattern of somatotroph abundance and preceding the increase in plasma GH levels. GH secretion can be induced earlier (e11 and e12) in vivo and in vitro in the chicken by administration of Cort (10, 32) or in the pregnant rat by administration of dexamethasone (Dex) in the drinking water (36) . Cort induction of somatotroph differentiation involves the glucocorticoid (GC) receptor (GR) (3), and GR mRNA levels peak at e14, concomitant with the normal differentiation of GH cells in chickens (21) . GR protein is detected in pituitary extracts as early as e8, and GR is expressed in ϳ95% of all pituitary cells (3) . However, examination of 10 kb upstream and 5 kb downstream of the chicken, rat, and human GH genes revealed no full-length consensus GC response element (GRE), only imperfect half sites (45, 49) . Furthermore, induction of GH mRNA by Cort can be blocked in vitro by pretreatment of anterior pituitary cells from embryonic rats or chickens with a protein synthesis inhibitor (4, 35) , suggesting that one or more proteins must be first synthesized or that ongoing protein synthesis is necessary for GC induction of GH gene expression. The present study characterized GC regulation of the chicken GH gene in primary chicken embryonic pituitary (CEP) cells. The chicken is a unique model for studies of pituitary development, because there is little maternal interaction with the growing embryo, embryonic development is easily timed and controlled, and the pituitary is relatively large compared with rodent pituitary at the same stage of development, thus providing larger quantities of pituitary cells at a single embryonic age, which are necessary for cell culture experiments aimed at defining molecular mechanisms. The objectives of the present study were to define the GC-responsive region (GCRR) of the GH gene through deletion/mutation analysis of chicken GH promoter reporter constructs and to test for binding of specific proteins to this region using EMSAs and chromatin immunoprecipitation (ChIP). Uncovering the GC-inducible element in the GH gene and its associated trans-acting factors will aid in understanding the mechanisms regulating somatotroph differentiation and GH production in vertebrates.
MATERIALS AND METHODS
Reagents and materials. All reagents, including cell culture media, additives, transfection reagents, and enzymes, were purchased from Invitrogen (Carlsbad, CA), unless otherwise noted. Hormones, oligonucleotides, and other chemicals were obtained from Sigma Aldrich (St. Louis, MO).
Generation of deletion and mutant luciferase reporter constructs. Deletion constructs were made using the Ϫ1727/ϩ48 chicken GH pGL3 luciferase reporter (a generous gift from Dr. Frederick C. Leung, School of Biological Sciences, The University of Hong Kong, Hong Kong, PR China) was used as the template in PCR amplification with a proofreading DNA polymerase. The primers and restriction enzymes are listed in Table 1 . Mutant constructs were generated in the Ϫ1045/ϩ48 GH reporter using the QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA). After transformation of DH5␣ Max Efficiency Competent cells with the newly ligated plasmids, ampicillin-selected colonies were chosen. Plasmids were sequenced to confirm the sequence and orientation of inserts. Nucleobond Maxi plasmid purification columns (Clontech, Mountain View, CA) were used to purify plasmids for transfection.
Pituitary dissection, dispersion, cell culture, and transfection. Fertilized chicken eggs (Ross broiler strain) were set in a humidified incubator (60% humidity, 37.5°C), with day 1 of incubation denoted as e0. Pituitaries were dissected from e11 embryos and trypsindispersed, as previously described (41) . Cells were counted and viability was assessed by the trypan blue dye-exclusion method (23) .
In all experiments, cell viability was Ͼ95%, and an individual e11 pituitary gland yielded ϳ3 ϫ 10 5 cells. Dispersed cells were plated at a density of 1 ϫ 10 6 cells per well in poly-L-lysine-coated 24-well plates and allowed to attach for 1 h. Plasmids to be transfected were diluted in sterile OptiMEM to a concentration of 1 g per well for all pGL3 vector constructs and 0.01 g per well for the Renilla luciferase plasmid used for normalization. Diluted plasmids were combined with Lipofectamine, and plated cells were transfected with the OptiMEMLipofectamine-plasmid mixture for 4 h. The medium was replaced with DMEM-Ham's F-12 medium supplemented with 0.1% BSA, 100 U/ml penicillin, 100 g/ml streptomycin, and 5 g/ml human insulin, and the cells were cultured for an additional 20 h. Cort (100 nM final concentration) was added to appropriate wells for an additional 20 h, and the cells were lysed with passive lysis buffer according to the manufacturer's instructions in the Dual Luciferase Reporter assay kit (Promega, Madison, WI). Treatment with 100 nM Cort for 20 h was based on previous experiments (4, 10, 32) .
Analysis of luciferase mRNA in transfected cells. CEP cells from e11 embryos were dispersed, plated at a density of 4 ϫ 10 6 cells per well, and transfected with the Ϫ1727/ϩ48 GH reporter (1.45 g), Renilla luciferase plasmid (0.01 g), and a Golgi-targeted green fluorescent protein (GFP) expression plasmid (1.45 g) (38), as previously described (14) . At 22.5 h posttransfection, the cells were treated with cycloheximide (CHX, 10 g/ml), and Cort (1 nM) was added 90 min later at 24 h posttransfection. The cells were incubated for another 21 h, collected, and washed once with serum-free MEM, once with DMEM, and once with PBS. The cells were then sorted on the basis of GFP fluorescence (fluorescence detection at 509/489 nm) using a cell sorter (FACSAria III, Becton-Dickinson, San Jose, CA). The sorted cells were collected into RLT buffer from the RNeasy Mini Kit (Qiagen, Valencia, CA) for immediate RNA extraction following the manufacturer's protocol with the optional on-column DNA digestion, and resulting RNA was quantified using the Ribogreen quantitation kit. The RNA was reverse-transcribed into cDNA and used in a quantitative PCR using an iCycler (Bio-Rad, Hercules, CA), as previously described (13) . All primers used to quantify mRNA are listed in Table 2 . Primers were designed to span an intron where appropriate to ensure amplification of mRNA, and not genomic DNA. Relative mRNA levels for each sample were calculated using the relative cycle threshold (C t) method [mRNA level ϭ 2 (Ct of the no-RT control Ϫ Ct of the sample) ], as described previously (13, 15) . Levels of mRNA were then normalized to levels of ␤-actin or Renilla luciferase mRNA, as noted. 6 per treatment) were cultured for 6 h in the presence or absence of Cort (1 nM). Cells were scraped on ice, collected into 15-ml centrifuge tubes, and rinsed once with PBS. The nuclear and cytoplasmic fractions were isolated according to the method described previously with modifications (11) . The cells were washed once in hypotonic buffer [10 mM HEPES (pH 7.9), 10 mM KCl, 1.5 mM MgCl 2, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), and 0.5 mM DTT], resuspended in hypotonic buffer, and incubated on ice for 10 min. The cells were then transferred to a 1-ml Dounce homogenizer fitted with a tight pestle and homogenized with 60 up-and-down strokes. An aliquot of cells was checked under a microscope for loss of cell membrane and retention of nuclei with trypan blue. The nuclei were then transferred to a microcentrifuge tube and centrifuged at 3,300 g for 15 min. The cytoplasmic fraction was removed and saved. The nuclear pellet was rapidly resuspended in low-salt buffer [20 mM HEPES (pH 7.9), 25% glycerol, 0.02 M KCl, 1.5 mM MgCl 2, 0.2 mM EDTA, 0.02 PMSF, and 0.05 mM DTT] at 4°C. An equal volume of high-salt buffer [20 mM HEPES (pH 7.9), 25% glycerol, 1.4 M KCl, 1.5 mM MgCl 2, 0.2 mM EDTA, 0.02 PMSF, and 0.05 mM DTT] was added drop-wise during thorough mixing of the contents of the tube between additions. The sample was placed on a rotator (end-to-end) at 4°C for 30 min and centrifuged for 30 min at 16,000 g. The buffer in the nuclear extract was replaced with binding buffer (10 mM Tris, 50 mM NaCl, and 1 mM DTT, pH 7.5) using Microcon centrifugal filter devices (YM-10, Millipore, Billerica, MA) following the manufacturer's instructions. The sample was quantified using Coomassie Plus: The Better Bradford Reagent (Pierce), with absorbance at 560 nm.
EMSA. Single-stranded (sense and antisense) 5=-infrared dye-labeled (IRDye 700) probes designed for the proximal (Ϫ1042/Ϫ956) and distal (Ϫ1496/Ϫ1465) GCRR and exon 3 (ϩ207/ϩ237) of the chicken GH gene (Table 3) were purchased from Integrated DNA Technologies (Coralville, IA). Double-stranded probes were prepared by mixing equal amounts of the single-stranded cDNAs, heating to 95°C for 5 min, and slow cooling to room temperature. One microliter of annealed probe (50 nM final concentration) and 2.5 g of nuclear extract proteins were added to the binding reaction. The binding reaction, which consisted of binding buffer (10 mM Tris, 50 mM NaCl, and 1 mM DTT, pH 7.5), 50 ng of sheared salmon sperm DNA, and 5 mM MgCl2, 2.5 mM DTT, 0.25% Tween 20, and 0.2% NP-40, was incubated for 30 min on ice in darkness. After addition of orange loading dye (LI-Cor Biosciences, Lincoln, NE), the DNA-protein complexes were separated by electrophoresis (for 3 h at 70 V) on nondenaturating 7% polyacrylamide-Tris-borate-EDTA gels and scanned directly (intensity level 8) using the Odyssey infrared imaging system (Li-Cor Biosciences).
Western blotting. To determine if Cort treatment affected expression of ETS-1 protein, e11 anterior pituitary cells (5 ϫ 10 6 cells per well) were cultured for 24 h and left untreated or treated with Cort (1 nM) for the final 1.5, 3, or 6 h of culture. Cells were placed on ice, gently rinsed once with ice-cold PBS, and incubated on ice with rocking for 5 min in nondenaturing cell lysis buffer containing protease and phosphatase inhibitors [20 mM Tris·HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerophosphate, 1 mM Na3VO4, 1 g/ml leupeptin, and 1 mM PMSF]. Cells were then scraped, sonicated on ice (3 times for 10 s each), and centrifuged at 14,000 g and 4°C for 10 min, and the supernatant was stored at Ϫ80°C until analysis. Protein levels in each sample were quantified with the micro-bicinchoninic acid protein assay kit (Pierce). Extracts (10 g of total cellular protein) were boiled in Laemmli sample buffer [60 mM Tris·HCl (pH 6.8), 100 mM DTT, 2% SDS, 10% glycerol, and 0.01% bromophenol blue] for 5 min, resolved on a 10% gel by SDS-PAGE with Tris-glycine buffer (25 mM Tris and 192 mM glycine) containing 0.1% SDS, and transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P, Millipore) for 30 min at 16 V and for 1 h at 25 V using a Trans-Blot SD semi-dry electrophoretic transfer cell (Bio-Rad) in Tris-glycine buffer containing 20% methanol. Membranes were washed for 15 min with TBS-T (20 mM Tris·HCl, 136 mM NaCl, 0.1% NaCl, and 0.1% Tween 20, pH 7.6), blocked for 2 h at room temperature in TBS-T containing 5% nonfat dry milk, and incubated overnight at 4°C with rabbit polyclonal antibody against human ETS-1 (1:1,000 dilution; catalog no. sc-112, Santa Cruz Biotechnology, Santa Cruz, CA) or a mouse monoclonal antibody against chicken ␣-tubulin (1:500 dilution; Santa Cruz Biotechnology) diluted in TBS-T containing 1% nonfat dry milk. The membranes were washed three times for 5 min each with TBS-T and incubated for 2 h with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (1:2,000 dilution; Cell Signaling Technology, Danvers, MA) diluted in TBS-T containing 5% nonfat milk. Immunoreactive bands were detected using enhanced chemiluminescent detection reagents (LumiGLO, Cell Signaling Technology) and the ChemiDoc XRS system equipped with Quantity One software (version 4.5.2, BioRad). Quantification of the Western blot is presented as mean band intensity for ETS-1 divided by mean band intensity for ␣-tubulin (n ϭ 2 replicate experiments).
To identify proteins that bound to the GCRR, proteins from the acrylamide gel used for the EMSA were transferred to PVDF membranes, and immunoblotting for ETS-1 was performed as described above. For Western blotting of GR, the membrane was incubated overnight at 4°C with the mouse monoclonal anti-rat GR antibody GR49-4, which recognizes chicken GR, as shown previously (17) (1:1,000 dilution; kindly provided by Dr. Lily Vardimon, The George S. Wise Faculty of Life Sciences, Tel Aviv, Israel, with permission from Dr. H. Westphal, Institute of Molecular Biology and Tumor Research, Marburg, Germany), and GR was detected using horseradish peroxidase-conjugated anti-mouse IgG (1:5,000 dilution; Amersham Biosciences, Piscataway, NJ). Immunoreactive bands were detected as described above.
Pull-down assay. LMH cells (CRL-2117, American Type Culture Collection; 2 ϫ 10 5 ) were transfected using OptiMEM-Lipofectamine for 6 h according to the manufacturer's protocol with 1 g of chicken Ets1A (accession no. JQ086323) or Ets1B (accession no. JQ086324) cloned from e18 pituitary RNA samples into pSport expression plasmid. At 18 h after transfection, cells were treated with 100 nM Cort. After another 24 h, cells were lysed in lysis buffer as described above, and protein concentration was determined using Coomassie Plus reagent. For 10 min, 150 g of total protein were precleared using 50 ng of sheared salmon sperm DNA per 1 g of total protein in EMSA binding buffer (10 mM Tris, 50 mM NaCl, and 1 mM DTT, pH 7.5) and 50% slurry (washed twice with PBS) of streptavidinagarose resin (Thermo Scientific, Rockford, IL). Equal volumes of precleared supernatants were incubated with 1 g of double-stranded 5=-biotinylated GCRR or mutated GCRR probes (Integrated DNA Technologies) overnight at 4°C with gentle rocking. Then 25 l of streptavidin-agarose beads (50% slurry, washed twice with PBS) were added and incubated for 2 h at 4°C with gentle rocking. Beads with bound proteins were recovered by centrifugation and washed twice with TE buffer (10 mM Tris, 1 mM EDTA, and 100 mM NaCl, pH 7.4), twice with EMSA binding buffer, and once with PBS buffer. After the final wash, beads were suspended in Laemmli sample buffer, boiled to release bound proteins, and subjected to SDS-PAGE and Western blotting, as described above.
Cell culture and chromatin preparation. CEP cells (e11; 2.5 ϫ 10 6 cells per treatment) were plated in 6 ml of DMEM-Ham's F-12 medium (supplemented with 0.1% BSA, 100 U/ml penicillin, 100 g/ml streptomycin, and 5 g/ml human insulin) in four 100 ϫ 20 mm Corning cell culture petri dishes and allowed to recover overnight. The cells were then treated with vehicle or Cort (1 nM) for 1.5 or 6 h and fixed with formaldehyde (1.2% final concentration) on a rotator for 10 min at room temperature. Glycine (0.1 M final concentration) was then added for 5 min to quench the formaldehyde. The plates were placed on ice, and the cells were scraped into 50-ml conical tubes. The dishes were washed twice with 2 ml of ice-cold PBS-1 mM PMSF. The cells were collected by centrifugation at 3,000 g, and the pellet was washed once with PBS-1 mM PMSF. The cells were resuspended in swelling buffer [25 mM HEPES (pH 7.8), 1.5 mM MgCl2, 10 mM KCl, 0.1% NP-40, 1 mM DTT, 0.5 mM PMSF, and 1ϫ Halt protease inhibitor cocktail (Thermo Scientific)] and incubated on ice for 10 min. The cell suspension was homogenized with a 15-ml Dounce homogenizer with 15 up-and-down strokes using a loose-fitting pestle, transferred to 15-ml conical tubes, and centrifuged at 1,800 g for 5 min. The nuclear pellet was resuspended in 2 ml of micrococcal nuclease buffer [0.32 M sucrose, 50 mM Tris·HCl (pH 7.4), 4 mM MgCl 2, 1 mM CaCl2, 0.1 mM PMSF, and 1% SDS] and homogenized with a Polytron (model PT 1200 C, Kinematica, Bohemia, NY) for 30 s on ice. After addition of 10 l of BSA and 7.5 l of micrococcal nuclease (New England Bio Labs, Ipswich, MA) to each sample, the reaction was incubated at 37°C for 15 min. The reaction was stopped by addition of 100 l of 0.5 M EDTA. The samples were stored overnight at Ϫ80°C. On the next day, the samples were sonicated in an ethanol-ice bath for 5 cycles (20-s continuous pulse, output at 60%, power setting of 6) using a Branson Sonifier 250 (Apollo Ultrasonics). The samples were centrifuged at 16,000 g for 10 min, and the supernatant was collected into a new tube and quantified using a Quant-it Picogreen DNA quantification kit (Invitrogen). Aliquots of the quantified chromatin were stored at Ϫ80°C. Gel electrophoresis confirmed that chromatin was sheared to 200 -800 bp.
ChIP. For each immunoprecipitation, 10 g of sheared chromatin were precleared twice for a total of 24 h at 4°C, with rotation using prewashed protein A magnetic beads (New England Bio Labs) and 0.25 mg/ml normal rabbit serum. The cleared chromatin was transferred to a new tube, 5 l of the appropriate antibody were added, and the tube was incubated overnight at 4°C with rotation. Before antibody addition, 2% of the total volume was removed and set aside as "input control." The following antibodies were used: normal rabbit serum (catalog no. 869019, CalBiochem, Darmstadt, Germany), rabbit polyclonal anti-human histone H3 COOH-terminal (catalog no. 39163, Active Motif, Carlsbad, CA), rabbit polyclonal anti-human ETS-1 (1:1,000 dilution; catalog no. sc-112; Santa Cruz Biotechnology), and mouse monoclonal anti-rat GR antibody GR49-4, which recognizes chicken GR, as shown previously (17) (1:1,000 dilution). The chromatin was then incubated with prewashed protein A magnetic beads (New England Biolabs) for 5 h at 4°C with rotation. The beads and immunoprecipitation reaction were washed twice with low-salt wash buffer [50 mM HEPES (pH 7.9), 140 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS, 0.5 mM PMSF, and 1ϫ protease inhibitor cocktail], high-salt wash buffer [50 mM HEPES (pH 7.9), 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate, 0.1% SDS, 0.5 mM PMSF, and 1ϫ protease inhibitor cocktail], LiCl wash buffer [20 mM Tris (pH 8.0), 1 mM EDTA, 250 mM LiCl, 0.5% NP-40, 0.5% Na-deoxycholate, 0.5 mM PMSF, and 1ϫ protease inhibitor cocktail], and TE buffer [10 mM Tris (pH 8.0) and 1 mM EDTA]. The immunoprecipitated chromatin was eluted from the beads with elution buffer [50 mM Tris (pH 8.0), 1 mM EDTA, 1% SDS, and 50 mM NaHCO3] at 65°C with rotation for 30 min. The supernatant (400 l) was transferred to new tubes containing 15 l of 5 M NaCl and 25 ng of RNase A and incubated at 37°C for 30 min. Then 250 ng of proteinase K (Sigma Aldrich) were added, and the samples were incubated at 65°C with rotation overnight. The samples were purified using the Wizard SV PCR clean-up kit according to the manufacturer's instructions (Promega) with the following modification: the final product was eluted twice with 40 l of water.
Real-time PCR of immunoprecipitated chromatin. Real-time quantitative PCR was used to quantify immunoprecipitated DNA levels using iCycler (Bio-Rad). The final concentration of the reaction mixture was 0.1% Triton X-100, 10 mM Tris·HCl, 50 mM KCl, 1.9 mM MgCl2, 2 U Taq, 10 mM each dNTP, 80 nM each primer, 20 nM fluorescein, and SYBR Green II nucleic acid gel stain (diluted 1:10,000). In each 30-l reaction, 4 l of the immunoprecipitated DNA were used. The primers are listed in Table 4 . The cycling parameters were as follows: 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. The starting input fraction was 2%; therefore, a dilution factor of 50, or 5.64 cycles (i.e., log 2 of 50), was subtracted from the Ct value of the diluted input to adjust input Ct values to 100% efficiency. All values were then adjusted to percentage of input using the following equation: 100 ϫ 2 (adjusted input Ct Ϫ sample Ct) (18) . Statistical analysis. Each experiment was replicated three to five times using completely separate CEP cell isolations. The SAS statistical analysis system (SAS, Cary, NC) was used to determine statistically significant differences among treatments or groups with a mixed-model ANOVA, where replicate experiment was a random effect in the model. An a priori test of least significant differences with Tukey's method of adjustment to control the experiment-wise error rate was used to determine significant differences among groups. Differences were considered significant at P Ͻ 0.05.
Firefly luciferase was normalized to Renilla luciferase, and then relative luciferase data were transformed into logarithmic scale to correct for heterogeneity of variances among groups and nonnormality. The least-squared means were backtransformed and then normalized to the Ϫ1727/ϩ48 plasmid, or a different plasmid as indicated, for graphical representation. Correction for heterogeneity of variances may have contributed to an inflated standard error in some experiments. Real-time quantitative RT-PCR values for firefly luciferase or GH mRNA were normalized to Renilla luciferase or ␤-actin mRNA, respectively. The ⌬⌬C t value was then used for significance testing. The log2 data were backtransformed for graphical representation.
RESULTS
The Ϫ1727/ϩ48 insert responds robustly to Cort in CEP cells. It was reported previously that Dex treatment produced a twofold increase in promoter activity of a luciferase reporter construct containing 1,775 bp of the 5=-flanking region of the chicken GH gene when transfected into rat GH 4 C l cells (24) . In that report, deletion of the Ϫ1,727-bp insert to Ϫ1,467 bp ablated Dex induction of promoter activity (24) . Therefore, it is possible that a nonclassical GRE exists between Ϫ1,727 and Ϫ1,467 bp of the chicken GH gene. To confirm Cort responsiveness of the Ϫ1727/ϩ48 chicken GH reporter in homologous pituitary cells, this reporter was transfected into e11 CEP cells. The Ϫ1727/ϩ48 region of the GH gene increased basal luciferase activity by twofold (Fig. 1A) , while the Ϫ1467/ϩ48 GH reporter resulted in a 50% increase in basal luciferase activity. Cort did not affect luciferase activity of the empty vector. In contrast, Cort increased luciferase activity of the Ϫ1727/ϩ48 GH reporter by sixfold. However, the Ϫ1467/ϩ48 GH reporter was not Cort-responsive (n ϭ 3, P Ͼ 0.05; Fig.  1A) . Thus, the Ϫ1727/ϩ48 GH reporter was Cort-responsive in GH 4 C 1 cells (data not shown) and CEP cells, and this response was lost with deletion down to Ϫ1467. Inspection of Ϫ1727 to Ϫ1467 bp of the GH gene revealed no GRE. However, a half site of a canonical GRE is located in intron 1 (ϩ302 to ϩ320 bp) of the chicken GH gene. To address whether the purported GRE half site in intron 1 is functional, Ϫ1727 to ϩ1004 bp of the GH gene was cloned into a luciferase reporter and tested in CEP cells (Fig. 1B) . Cort treatment of the Ϫ1727/ϩ48 GH reporter resulted in a 12-fold increase in luciferase activity. However, Cort treatment of the Ϫ1727/ϩ1004 GH reporter resulted in only a sixfold increase in luciferase activity (n ϭ 4; P Ͻ 0.05) in these trials. Thus, inclusion of intron 1 and the GRE half site did not increase responsiveness to Cort. Next, e11 CEP cells were treated with vehicle or various steroids, Cort, aldosterone, testosterone, estradiol, and progesterone (100 nM), to define the specificity of the response to Cort. Cort treatment induced the Ϫ1727/ϩ48 GH reporter by 10-fold (n ϭ 3, P Ͻ 0.05; Fig. 1C ), whereas treatment with aldosterone, testosterone, or estradiol did not produce a significant increase. Progesterone resulted in a partial increase in luciferase activity that was significantly lower than the response to Cort. Therefore, the Ϫ1727/ϩ48 GH reporter response was relatively specific to Cort. The Ϫ1727/ϩ48 GH reporter recapitulates Cort induction of the endogenous GH gene. Induction of GH mRNA in CEP cells by GC can be blocked with the addition of CHX, a protein synthesis inhibitor, possibly indicating the necessity of an unknown protein in Cort induction of GH. Therefore, induction of the Ϫ1727/ϩ48 GH reporter by GC and subsequent inhibition of that induction by CHX would be necessary for the reporter to recapitulate the natural system. To this end, mRNA levels of firefly luciferase and Renilla luciferase in response to Cort and CHX alone and in combination were quantified using quantitative RT-PCR. Firefly luciferase mRNA was normalized to Renilla luciferase mRNA as a control for transfection efficiency ( Fig. 2A) . Firefly luciferase mRNA transcribed off the Ϫ1727/ϩ48 GH reporter increased 80-fold in response to Cort, and this response to Cort was blocked by pretreatment with CHX. GH mRNA, normalized to ␤-actin, was quantified in the same samples (Fig. 2B) . Cort induced GH mRNA, regardless of the transfected reporter (Ϫ1727/ϩ48 vs. empty vector), and Cort induction of GH mRNA was blocked by pretreatment with CHX, as expected. Thus, ongoing protein synthesis is required for Cort induction of the Ϫ1727/ϩ48 GH reporter and the endogenous GH gene.
Deletion constructs reveal two potential GCRRs. For identification of the GCRR within the 5=-flanking region of the chicken GH gene, the Ϫ1727/ϩ48 GH reporter was used as template to generate progressively shorter deletion constructs. Eleven deletion constructs were cloned into the luciferase vector and tested for Cort responsiveness (Fig. 3A) . The Ϫ1467/ϩ48 GH reporter remained unresponsive to Cort, while the Ϫ1477 clone was minimally responsive. The shorter Ϫ1430/ϩ48, Ϫ1398/ϩ48, Ϫ1201/ϩ48, and Ϫ1045/ϩ48 GH reporter constructs were responsive to Cort (P Ͻ 0.05, n ϭ 3), while the Ϫ954/ϩ48, Ϫ807/ϩ48, and Ϫ382/ϩ48 GH reporters were not responsive to Cort (P Ͼ 0.05, n ϭ 3; Fig. 3 ). Therefore, a GC inhibitory region (GC-IR) was identified between Ϫ1477 and Ϫ1430, and a proximal GCRR was identified between Ϫ1045 and Ϫ954 of the chicken GH gene.
The GCRR is orientation-independent but context-dependent. We next sought to further characterize the Ϫ1045 to Ϫ954 GCRR. To this end, 10 additional constructs were made to test whether the proximal GCRR is orientation-and/or context-independent (Fig. 4) . The GCRR was placed into other deletion constructs in the forward and reverse directions. Constructs were transfected into CEP cells and treated with Cort. The GCRR exhibited greater Cort responsiveness when placed in the reverse orientation (n ϭ 4, P Ͻ 0.05; Fig. 4) . Addition of the reverse GCRR to the Ϫ1727/ϩ48 and Ϫ954/ϩ48 constructs resulted in an average 35-fold increase in luciferase activity, but only in a 13-fold increase in luciferase activity when placed in front of the Ϫ650/ϩ48 construct. Placement of the GCRR in the forward orientation linked to the Ϫ650/ϩ48 construct resulted in an apparent twofold response to Cort, but this was not significant. The Ϫ1727/ϩ48 construct, with Ϫ953 to Ϫ650 deleted but the GCRR intact, did not respond to Cort. Similarly, when the GCRR, in either orientation, was linked to the Ϫ382/ϩ48 GH reporter, Cort induction of luciferase activity was lost (data not shown). This suggests that intervening sequences between Ϫ650 and Ϫ382 bp of the GH gene, including the distal Pit-1 site (Ϫ541/Ϫ528), are required for Cort induction of GH promoter activity. Taken together, these results indicate that responsiveness to Cort through the GCRR (Ϫ1045/Ϫ954) requires cis-acting elements between Ϫ650 and Ϫ382 and additional elements between Ϫ953 and Ϫ650. However, responsiveness to Cort was conferred in constructs containing Ϫ953/ϩ48 when the GCRR was included in its forward or reverse orientation. Therefore, Cort responsiveness of the GCRR is orientation-independent but context-depen- dent. With use of the vertebrate database in the MatInspector (43) and JASPAR CORE (44) programs, putative transcription factor binding sites were identified between Ϫ1045 and Ϫ954 of the chicken GH gene. Interestingly, a degenerate GRE half site (dGRE) and an ETS-1 site were identified by both programs.
Nuclear proteins bind to the GCRR in a Cort-regulated manner. Next, using EMSA, we sought to determine if the putative transcription factor binding sites within the GCRR were functional in vitro. Nuclear proteins extracted from Cortor vehicle-treated CEP cells incubated with the Ϫ1045 to Ϫ954 GCRR probe (Table 3 ) produced a noticeable shift in mobility of the probe (Fig. 5) . One high-molecular-weight and one low-molecular-weight shift were observed upon incubation of nuclear extracts with the GCRR probe. Cort treatment increased binding of high-and low-molecular-weight nuclear proteins to the GCRR probe. The high-molecular-weight band was not seen in all experiments, however, so we focused our attention on the lower-molecular-weight band. Quantification of the mean integrated intensity of the shifted band showed that Cort treatment significantly increased binding of proteins to the GCRR probe (P Ͻ 0.05; Fig. 5 ). Nuclear proteins incubated with a probe corresponding to a region within exon 3 (ϩ207/ ϩ237) or a probe designed within a more distal segment of the 5=-flanking region (Ϫ1566 to Ϫ1467) did not produce an observable shift in mobility of either control probe. Serial dilution of the GCRR probe used in the gel shift assays (diluted 1:4) demonstrated that binding was concentration-dependent (data not shown). Similarly, when the amount of nuclear protein incubated with the probe was serially diluted 1:1, intensity of the shifted band was reduced (data not shown).
To determine if the observed shift with the GCRR probe was specific, three unlabeled double-stranded DNA competitors were made: one corresponded to the immediate upstream region (Ϫ1201 to Ϫ1046) of the GH gene, one to the 5= half of the GCRR probe, and one to the 3= half of the GCRR probe (Fig. 6A) . Nuclear extracts were preincubated with the 5= competitor, the 3= competitor, or the upstream competitor in 100-fold molar excess for 30 min prior to addition of the GCRR probe. Extracted nuclear proteins from CEP cells produced an observable shift of the GCRR probe. Addition of the 5= or 3= competitor resulted in reduced protein binding to the probe, while addition of the upstream competitor did not affect protein binding to the probe (n ϭ 4; data not shown). Thus, nuclear protein binding to the GCRR probe is Cort-regulated, and binding can be competed off with addition of a 5= competitor or a 3= competitor. Because the 5= and 3= competitors reduced binding to the probe and did not provide additional insight into the region bound by proteins, another competitor was made. An unlabeled competitor corresponding to the center 34 bp of the GCRR probe and spanning the putative ETS-1 and GR binding sites was tested with the nuclear extracts (Fig. 6B) . Nuclear extracts were preincubated with the upstream competitor or the centered competitor in 100-fold molar excess for 30 min prior to addition of the GCRR probe. Addition of the centered competitor abolished protein binding to the GCRR probe. Addition of the upstream competitor did not affect protein binding to the probe (n ϭ 4; Fig. 6B ). Taken together, the GCRR probe binds nuclear proteins in a Cortregulated manner, and this binding can be competed-off with competitor DNA corresponding to the central 34 bp spanning the putative ETS-1 site and dGRE half site. To confirm specificity of protein binding to the GCRR, the central 34 bp of the GCRR probe were scrambled twice, using a free-source randomized-sequence program (http://workbench.sdsc.edu) and reinserted into the full-length GCRR probe sequence (Fig. 7A , Table 3 ). The wild-type and mutant probes were incubated with increasing amounts of nuclear proteins extracted from basal or Cort-treated e11 pituitary cells (Fig. 7B) . The shifted band intensity with the GCRR probe increased with increasing amounts of protein. A shifted band of the same molecular weight was also observed with the mutant probe; however, intensity of the shifted band with the mutated probe was significantly reduced (Fig. 7C ; n ϭ 3, P Ͻ 0.05). These results indicate that the central 34 bp of the GCRR containing the putative ETS-1 site and dGRE half site are important for nuclear protein binding.
ETS-1 binds to the GCRR probe in vitro.
Next, we tested whether ETS-1 expression was responsive to Cort in CEP cells. ETS-1 was evaluated, because it has been shown to be involved in regulation of prolactin and GH gene expression in other species (5, 51) . We found that Cort induces GH mRNA after 6 h of treatment, but it does not affect ETS-1 mRNA levels (Fig. 8A) . Consistent with this, we found that ETS-1 protein expression was not affected by Cort (1 nM) treatment of e11 CEP cells for 1.5, 3, or 6 h (Fig. 8B) . Next, using EMSA and pull-down assays, we tested for ETS-1 binding to the GCRR probe. To identify proteins that bind the GCRR probe, Fig. 6 . EMSA with competitors. A: schematic of competitors. B: nuclear protein extracts were preincubated with competitors in 100-fold excess for 0.5 h. The GCRR probe was added for an additional 0.5 h; then the reaction was loaded onto the gel. A centered competitor was used to determine where proteins bind along the length of the GCRR probe (Table 3) . Blot represents results from 3 replicate experiments. dGRE, degenerate GC response element. e11 CEP cells were treated with vehicle or Cort (1 nM) for 6 h, and nuclear proteins were extracted (n ϭ 4). The nuclear extracts were incubated with the GCRR probe and visualized (Fig. 8C, right) . The proteins from the acrylamide gel were then transferred to PVDF membranes and probed for ETS-1 and GR. The GR antibody did not detect any proteins (data not shown). However, ETS-1 was detected in the proteins that bound the GCRR probe (Fig. 8C, left) . Similarly, pull-down assays demonstrated binding of overexpressed ETS-1A and ETS-1B protein to a biotinylated GCRR probe (Fig. 8D) . In contrast, binding of ETS-1 proteins to the mutated GCRR probe was strongly attenuated (Fig. 8D) . These results indicate that chicken ETS-1 proteins can bind to the GCRR in vitro.
ETS-1 and GR are associated with the GCRR in the endogenous GH gene. ChIP was performed on e11 CEP cells that were untreated or treated with Cort (1 nM) for 1.5 and 6 h. Approximately 220 e11 pituitary glands were isolated for each replicate experiment. Chromatin was immunoprecipitated with normal rabbit serum and antibodies against histone H3, GR, and ETS-1. Real-time quantitative PCR was performed on the immunoprecipitated chromatin using primers (Table 4) corresponding to the GCRR (Ϫ1065 to Ϫ869) and a 5= distal region (Ϫ2187 to Ϫ2037) and a 3= region corresponding to the nascent GH transcript (ϩ456 to ϩ596) as controls (Fig. 9) . The real-time PCR products of the GCRR, the 5=-distal control region, and the 3= control region after 40 cycles were visualized by agarose gel electrophoresis (Fig. 9A) . C t values from real-time PCR of the immunoprecipitated samples were normalized to the input chromatin values and analyzed by a three-way (region ϫ IP ϫ treatment) ANOVA (Fig. 9B) . All terms in the model were significant, as well as the three-way interaction (n ϭ 4, P Ͻ 0.05). ETS-1 and GR were associated with the GCRR under basal conditions. GR binding to the GCRR increased after 1.5 h of Cort treatment. After 6 h of Cort treatment, GR and ETS-1 binding to the GCRR decreased. Neither GR nor ETS-1 was associated with the 5=-distal control region or the 3= control region under any condition. Taken together, these results demonstrate that GR and ETS-1 are associated with their putative response elements in the GCRR of the GH gene in e11 CEP cells and that Cort affects binding of GR and ETS-1 to the GCRR of the endogenous GH gene.
Mutation of the ETS-1 and dGRE binding sites in the GH luciferase construct abolishes Cort responsiveness. The ChIP and EMSA results indicate that GR and ETS-1 are recruited to the GCRR. Therefore, the dGRE half site and the ETS-1 site in the Ϫ1045/ϩ48 GH reporter were mutated using site-directed mutagenesis to test for functionality of these sites in GC induction of GH gene transcription (Fig. 10A) . At e11, CEP cells were transfected with the basic reporter vector, wild-type Ϫ1045/ϩ48 GH reporter, ETS-1 mutant, or dGRE mutant plasmids (Fig. 10B) . Cort increased luciferase activity of the wild-type Ϫ1045/ϩ48 GH reporter, while the ETS-1 mutant and the dGRE mutant constructs were not responsive to Cort. These results demonstrate that the putative binding sites for ETS-1 and GR within the identified GCRR are necessary for GC regulation of the GH gene in CEP cells.
DISCUSSION
GC can induce expression of GH mRNA and protein in pituitary cells of embryonic chickens (40) and fetal rats (34) . The objective of the present study was to identify cis-acting ETS-1B to the biotinylated GCRR or biotinylated mutated GCRR probes was tested using pull-down assays. Proteins pulled down by the biotinylated probes were identified using Western blotting with an ETS-1-specific antibody.
elements and trans-acting factors underlying GC regulation of the GH gene. To this end, a luciferase reporter containing Ϫ1727/ϩ48 bp of the 5=-flanking region of the chicken GH gene was used to analyze Cort responsiveness of the GH gene in CEP cells. We determined that the Ϫ1727/ϩ48 GH reporter is an appropriate model for GC regulation of the endogenous GH gene, because luciferase mRNA transcribed off the Ϫ1727/ϩ48 GH reporter in response to Cort required ongoing protein synthesis, as did induction of endogenous GH mRNA. GC induction of the GH gene during fetal rat development also requires ongoing protein synthesis (35) . Thus, it is possible that the proteins required for this response are conserved between rats and chickens. Our findings indicate that the Ϫ1727/ϩ48 GH reporter recapitulates the endogenous gene and is an appropriate model for use in studies of GC regulation of the chicken GH gene.
Through deletion analysis of the Ϫ1727/ϩ48 GH reporter, two GCRR were identified in the present study: a proximal GCRR and a distal GCRR. This is the second study to show that the promoter of the chicken GH gene was responsive to GC. The Ϫ1727/ϩ48 GH reporter exhibited a twofold increase in response to Dex when transfected into a rat pituitary cell line (24) . This previous study characterizing the chicken GH gene concluded that a nonclassical GRE was located between Ϫ1727 and Ϫ1467 (24). The present study further defined this region, and we propose that there is a repressor region located between Ϫ1477 and Ϫ1430. However, further studies are necessary to determine the underlying mechanism of regulation by this region. The human GH gene has a GRE half site in the first intron that bound the GR complex in an exonuclease III protection/foot-printing assay (45) . The gene devoid of its GRE was nonresponsive to Dex treatment, and the intact gene containing its native GRE responded sixfold to Dex treatment (45) . Also, a putative GRE half site is located at ϩ302/ϩ320 with the sequence of TGTTCT in intron I of the chicken GH gene. However, the Ϫ1727/ϩ1004 construct containing intron I and the putative GRE half site was less responsive than the Ϫ1727/ϩ48 construct. Thus, we conclude that the putative GRE half site in intron 1 of the chicken GH gene is not necessary for Cort induction of the GH gene in CEP cells.
Our findings indicate that GC regulation of the GH gene is not dependent on the orientation of the proximal GCRR located between Ϫ1045 and Ϫ954. However, the GCRR was contextdependent. GC regulation of the GH gene in CEP cells is dependent on sequences contained in the Ϫ650/ϩ48 GH reporter. Mammalian GH genes contain two functional Pit-1 sites: a distal and a proximal site (26, 29) . Similarly, the chicken GH gene contains a distal Pit-1 site at Ϫ541/Ϫ528 and a proximal Pit-1 site at Ϫ113/Ϫ104 (24). Our findings suggest that the GH response to GC requires both Pit-1 sites or another unknown transcription factor that binds between Ϫ650 and Ϫ382. A transcription factor search using MatInspector was conducted on the Ϫ954 to Ϫ382 fragment. From Ϫ650 to Ϫ382, besides Pit-1, there are putative binding sites for CREB, STAT5, EVI1, ZNF35, MZF1, and the ETS-1 family members SPI1 and PU1. There are conserved putative binding sites for EVI1 and MZF1 in the dog, mouse, rat, and human GH genes (27) . CREB and STAT5 are known to be involved in regulation of the GH gene (8, 50) . We found that the GCRR in either orientation alone cannot confer Cort responsiveness to the thyroid-stimulating hormone-␤ promoter (data not shown), which requires Pit-1 for normal expression (19) . Therefore, it seems that other transcription factors, binding to sites outside the GCRR but within the GH 5=-flanking region, are required for Cort responsiveness. Thus, the GCRR was found to be orientation-independent and context-dependent in mediating GC induction of the GH gene.
Regulated protein binding to the GCRR was demonstrated using EMSA, and specificity of this binding to the central region of the GCRR was shown using unlabeled competitors and a mutant probe. The central portion of the GCRR contains putative binding sites for ETS-1 and GR. The 5= region of the GCRR contains a putative binding site for E47/CTCF, while the 3= region of the GCRR contains a putative binding site for RUSH/SMARCA3, a chromatin remodeling enzyme. These two proteins could also be involved in GC regulation of the GH gene. CCCTC binding factor (CTCF) is a zinc finger protein with ϳ100% conservation of the central DNA-binding domain between mouse, chicken, and human. CTCF has been implicated as a transcriptional repressor, activator, and insulator (39) . Interactions of CTCF with nuclear receptors are well characterized (1, 7, 9, 30) . However, there is no evidence that CTCF interacts with GR. This is the first study to demonstrate that GR and ETS-1 are associated with the promoter of the GH gene during embryonic development. We also demonstrated nuclear protein binding to the GCRR probe in vitro. One of the proteins contained in the protein-probe complex was identified as ETS-1 by Western blotting, and binding of chicken ETS-1 to the GCRR was confirmed by pull-down assays. ETS-1 mRNA and protein were not regulated by Cort treatment; however, the phosphorylation state of ETS-1 was not explored in this study. ETS-1 binds to DNA when its serine-rich region is phosphorylated (28, 31, 42) . ETS-1 and GR were shown to be associated with the GCRR by ChIP assays. Therefore, GC regulation of the GH gene during chicken embryonic development involves recruitment of proteins, including GR and ETS-1, to the GCRR.
A requirement for GR binding to the GCRR is supported by our finding that mutation of the dGRE half site in the Ϫ1045/ ϩ48 GH reporter abolished the Cort response. There is mounting evidence that GREs are more degenerate than previously thought. Two recent studies demonstrated functional GR binding to a dGRE, and not to a full-length classical GRE (46, 47) . The dGRE identified in the GCRR, although not a classical GRE, fits the classification described in those studies. Mutation of the ETS-1 site also rendered the Ϫ1045/ϩ48 GH reporter unresponsive to Cort. The ETS family of transcription factors consists of 10 family members that bind to a core sequence of GGAA. Five family members bind to the core sequence of CCGGAA (48) . It was also shown that functional redundant binding sites for all ETS-1 family members were more likely to occur close to the transcription start site of housekeeping-type genes, while more specific, nonredundant functional binding sites for individual ETS-1 family members occur farther away from the transcription start site of more specialized genes (22) . ETS-1 has been implicated as the other required factor in the regulation of transcription of the prolactin gene in the rat (5) . Pit-1 is necessary, but not sufficient, to direct GH expression in the pituitary in the rat, chicken, mouse, and human. Pit-1 is also necessary, but not sufficient, to direct prolactin expression in the rat pituitary. ETS-1 physically interacts with Pit-1 at a composite cis element to direct prolactin expression. The phosphorylation state of Pit-1 regulates its interaction with ETS-1 (2). Furthermore, binding of Pit-1 and ETS-1 to the composite site in the proximal promoter of the prolactin gene is necessary for Ras-MAPK activation of the prolactin promoter (12) . ETS-1 is also involved in regulation of the human GH gene through its locus control region (LCR). Activator protein-1 and the ETS family member Elk-1 were found to bind in hypersensitive site (HS) III and HS IV, respectively, of the human GH gene LCR (26) . Binding of these two transcription factors was associated with hyperacetylation of pituitary chromatin. This was the first study to implicate ETS-1 or an ETS family member in GH induction. In a follow-up study, it was shown that Pit-1 binds to HS I and HS II of the human GH normal (hGH-N) LCR, but it cannot bind to HS III alone (51) . This requires interaction with ETS-1 via Pit-1's POU homeodomain and a composite DNA binding element. ETS-1 and another ETS-1 family member, Elk-1, can be coimmunopre- cipitated from human pituitary extracts with a Pit-1 antibody, and overexpression of Elk-1 or Pit-1 alone or together could increase hGH-N expression in HEK-293 cells (51) . This was the first study demonstrating that Elk-1 could induce the GH gene. Elk-1 is an immediate downstream target of ERK. Pharmacological inhibition of ERK signaling blocks Cort induction of the chicken GH gene (unpublished data). Elk-1 belongs to the ternary complex family, a subfamily of the ETS family (6) . Members are downstream targets of the ras-Raf-MAPK kinase signaling pathway. This implies that the ETS-1 binding site in the GCRR is a necessary and essential element for GC regulation of the GH gene in CEP cells and suggests that ETS-1 may be interacting with Pit-1 in this regulation.
The ETS-1 site and dGRE half site in the GCRR of the chicken GH gene are separated by only 17 bp. This begs the following question: Do ETS-1 and GR physically interact? The rat tyrosine aminotransferase gene is induced by GC, and ETS-1 participates in this response (16) . The promoter of the cytochrome P-450 c27 multifunctional enzyme is GC-responsive and contains a functional GR binding site and an ETS-like site that binds ETS-2 in a GR-dependent manner that appears to synergistically activate the gene (33) . GR and ETS-2 were shown to coimmunoprecipitate in that study. A fusion protein consisting of only the GR DNA binding domain and the ETS-2 transcriptional activation domain recapitulated activation of the cytochrome P-450 c27 promoter, suggesting a novel synergy between these two proteins (33) . In the cytochrome P-450 c27 promoter, a GR binding site is flanked by two ETS-like binding sites and a CTCF binding site. The sites span a 50-bp region. The ETS-1 and dGRE putative sites in the chicken GH promoter span a region of 34 bp. Combinatorial transcription factor binding sites may allow for the integration of signaling from multiple external stimuli. Additional studies are necessary to determine if GR and ETS-1 physically interact during Cort induction of the chicken GH gene.
At first glance, 6-h ChIP results and the 6-h EMSA data from the present study do not agree. The EMSA results indicate that Cort increased protein binding, while the ChIP results indicate that GR and ETS-1 binding to the GCRR were diminished at 6 h after Cort treatment. However, there are inherent differences between EMSA and ChIP methodologies and the questions that the methods are able to answer. It is possible that another protein or protein complex is necessary to maintain association of ETS-1 and GR with the GCRR during GC regulation of the GH gene. Regardless, the ChIP results do agree with the mutant luciferase construct results. We showed that GR and ETS-1 are recruited to the proximal GCRR and that the dGRE and ETS-1 sites are necessary for GC regulation of the GH gene during chicken embryonic development. Furthermore, EMSA and ChIP results implicate binding of GR and ETS-1 to the GCRR of the GH gene in chickens. Although the time-specific recruitment of GR and ETS-1 does not agree on the basis of the EMSA and ChIP studies, we can speculate that GR and ETS-1 are recruited to specific sequences located in the GCRR of the endogenous GH gene and that they, in turn, recruit other proteins, including nucleosome remodeling enzymes, bridging proteins, and basal transcriptional machinery. This is followed by the unwinding of nucleosomes and the formation of an "open" chromatin conformation that is conducive to a high rate of gene transcription. Once gene transcription has moved into the elongation phase, it is possible that the bridging complex, consisting of GR, ETS-1, and cofactors, falls off the gene, so that maximum transcription can ensue. From our studies, GH transcription is maximal at 6 h after Cort treatment of e11 CEP cells (unpublished data).
In conclusion, we identified a functional dGRE half site and a functional ETS-1 site upstream of the GH gene that mediate GC responsiveness in the chicken. Collectively, our results indicate that ETS-1 is associated with its response element located at Ϫ1014 to Ϫ1009 upstream from the chicken GH gene under basal and Cort-treated conditions. GR is also associated with its response element located at Ϫ995 to Ϫ985, and on Cort treatment, GR recruitment is increased. Both cis-acting elements are required for GC induction of the GH gene. Additional elements contained in the Ϫ650 to ϩ48 region, such as Pit-1, are necessary for GC regulation. We demonstrated that each of these proteins binds to its own response element, and not to a composite element. We showed that ETS-1 is not a GC-regulated gene; however, it is not known whether ETS-1 or GR is phosphorylated in response to GC to affect their binding to the GCRR or interactions with other transcription factors, including Pit-1. The cumulative results from these studies raise new questions. Are bridging complexes or accessory factors necessary for GC induction of the GH gene? What is the target of CHX during GC regulation of the GH gene? It is unlikely to be ETS-1, GR, or Pit-1, inasmuch as Cort treatment did not increase expression of any of these factors. Finally, do GR, ETS-1, and Pit-1 physically interact to mediate GC induction of the GH gene?
Perspectives and Significance
We have known for decades that GCs can induce GH expression in cultures of pituitary cells from fetal rats and embryonic chickens (20, 32, 37) . However, the mechanism underlying this response has remained elusive. In the present study, we took advantage of the ability to isolate large numbers of precisely timed CEP cells to identify a region of the GH gene required for the GC response, the GCRR, and two transcription factors that bind to the GCRR and function in the GC response, GR and ETS-1. These findings have implications for the regulation of GH production and somatotroph ontogeny during embryonic development in vertebrates.
